© 2026
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Pocatello weather info
7/16 OUTAGE ALERT - Power outage at ISU has caused KISU to go off the air.
KISU-FM at 91.1 from Pocatello will operate at reduced power in July as we transition to a new FM tower site

Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed

NPR | By Sydney Lupkin
Published May 2, 2020 at 7:00 AM MDT

On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.

Copyright 2020 NPR
NPR Coronavirus Updates
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.
See stories by Sydney Lupkin